ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Efficacy"

  • 2020 American Transplant Congress

    The Learning Curve for Pure Laparoscopic Robotic Kidney Transplantation: An Analysis of Outcomes of the First 80 Consecutive Cases at a High-Volume Transplant Center

    F. Tinney Jr.1, J. Stracke2, T. Ivanics1, A. Elsabbagh1, J. Denny1, D. Kim1, L. Malinzak1, A. Yoshida1

    1Transplant Institute, Henry ford Hospital, Detroit, MI, 2Transplant Surgery, Metro Health Hospital, Wyoming, MI

    *Purpose: Robotic surgery is increasingly used in complex operations, including living-donor kidney transplantation. At this time, knowledge of the number of cases required to attain…
  • 2020 American Transplant Congress

    A Long-Term Follow-Up Study of High-Dose Intravenous Cyclosporine Combined Plasma Exchange in the Treatment of FSGS Recurrence after Renal Transplantation – A Single Center Clinical Experience

    Y. Cui, M. F. Wang, C. C. Wei, J. Y. Wu

    Kidney Disease Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China

    *Purpose: There was still lack of effective treatment for focal segmental glomerulosclerosis(FSGS)recurrence after renal transplantation. The purpose of this study was to explore the risk…
  • 2020 American Transplant Congress

    The Efficacy and Safety of Ischemia-Free Liver Transplantation (IFLT) in the Treatment of End-Stage Liver Disease in a Prospective, Randomized, Controlled Trial: A Report of the First 25 Cases

    X. He, Z. Guo, Q. Zhao, C. Huang, W. Ju, D. Wang, M. Chen, L. Wu, Y. Ma, Y. Chen, A. Hu, X. Zhu

    Organ Transplant Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China

    *Purpose: We’ve established a novel procedure called ischemia-free liver transplantation (IFLT). The results from the pilot study suggest that IFLT might prevent ischemia-reperfusion injury (IRI)…
  • 2020 American Transplant Congress

    A Video Education Intervention to Improve Kidney Transplant Knowledge and Willingness to Complete Transplant Evaluation in Dialysis Patients

    D. A. DuBay1, T. A. Morinelli1, Z. Sutton1, M. Chastain1, T. Thompkins Tindal1, Z. Su2, E. Weeda3, P. Mauldin4, M. Casey1, J. Bian2, D. Taber1, P. K. Baliga1

    1Surgery, Division of Transplant Surgery, Medical University of South Carolina`, Charleston, SC, 2General Internal Medicine, Medical University of South Carolina`, Charleston, SC, 3Clinical Pharmacy-Outcomes Sciences, Medical University of South Carolina`, Charleston, SC, 4General Internal Medicine, Medical University of South Carolina, Charleston, SC

    *Purpose: The Centers for Medicare and Medicaid Services has set a goal of 30% (currently 18.5%) of dialysis patients to be on a transplant (Tx)…
  • 2020 American Transplant Congress

    Thymoglobulin for Induction Less is Clearly More!

    N. Patel, P. Nicole

    -, -, SC

    *Purpose: The ideal total dose of anti-thymocyte globulin (ATG) is unknown in the African American (AA) kidney transplant population.The purpose of this study was to…
  • 2020 American Transplant Congress

    Effect of Therapeutic Plasma Exchange on Glomerular Filtration Rate in Patients with Acute Humoral Rejection

    M. Maza Moreno, S. Hernandez-Estrada, J. Cano Cervantes, D. Maldonado Tapia, M. Alamilla Sanchez

    Nephrology and Transplant Division, CMN 20 de Noviembre, Ciudad de Mexico, Mexico

    *Purpose: AMR is the main risk factor for graft loss, especially after the first post transplant year. Up to 80% of patients achieve response with…
  • 2019 American Transplant Congress

    Exploration of the Stanford Integrated Psychosocial Assessment for Transplant with Psychosocial and Medical Outcomes in Kidney/Kidney-Pancreas Transplant Recipients

    G. Chen1, C. Bell2, P. Loughhead1, B. Ibeche2, J. S. Bynon2, D. R. Hall2, A. M. De Golovine2, A. Edwards2, W. A. Dar2

    1Memorial Hermann Hospital, Houston, TX, 2The University of Texas Health Science Center at Houston McGovern Medical School, Houston, TX

    *Purpose: The Stanford Integrated Psychosocial Assessment for Transplant (SIPAT) is a psychometric instrument designed to improve organ transplant patient selection. However, limited studies have been…
  • 2019 American Transplant Congress

    A Comparison of the Safety and Efficacy of Apixaban Use in Renal Transplant vs. Non-Renal Transplant Recipients

    T. Loosier, K. Gutierrez, A. James, A. Dodson

    University of Alabama at Birmingham Hospital, Birmingham, AL

    *Purpose: Background: Utilization of direct-acting oral anticoagulants has become a preferred method for chronic anticoagulation in patients with atrial fibrillation (AF) or venous thromboembolism (VTE).…
  • 2019 American Transplant Congress

    Early Use of Everolimus Plus Reduced Tacrolimus vs Standard Tacrolimus in De Novo Livertransplant Recipients: 12 Months Efficacy and Safety Data from HEPHAISTOS Study

    B. Nashan1, P. Schemmer1, H. Schlitt1, A. Pascher1, C. Klein1, U. Neumann1, I. Kroeger2, P. Wimmer2, F. Braun1

    1Study Group, Hephaistos, Germany, 2Novartis Pharma GmbH, Nuernberg, Germany

    *Purpose: The HEPHAISTOS study was set up to compare early use of everolimus [EVR] combined with reduced tacrolimus [rTAC] versus standard-dose tacrolimus [TAC-C) in de…
  • 2019 American Transplant Congress

    Treprostinil as a Bridge Therapy to Heart-Lung Transplants with Severe Pulmonary Arterial Hypertension

    C. Ju, Q. Lian, B. Wei, X. Xu, J. He, R. Chen

    State Key Lab of the Respiratory Disease, Guangzhou Institute of Respiratory Disease, Guangzhou, China

    *Purpose: Heart-lung transplants (HLTx) is the only one effective strategy for advanced pulmonary arterial hypertension (PAH) with refractory right heart failure. But limited availability of…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 14
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences